Imatron receives order for five ultrafast ct(r) scanners
Mar 24, 1997 9:06 AM [PRNewswire]
From Medical Group in Malaysia
Contract Represents $13 Million in Revenues Over 2.5 Years
SO. SAN FRANCISCO, Calif., March 24 /PRNewswire/ -- Imatron Inc. (Nasdaq: IMAT) today announced that
the Company's commitment to focus sales efforts on international markets continues to yield results with the
receipt of an order for five Ultrafast CT(R) scanners from a medical investment group in Malaysia. The sales
contract represents $13 million in revenues to Imatron over the next two and a half years. The Company will
ship the first Ultrafast CT(R) scanner of the order in the first quarter of 1997, with the second scanner
scheduled to be shipped before the end of the year. These shipments signify Imatron's first penetration into
the market of Malaysia.
The Malaysian medical investment group, which is independent from and unaffiliated with Imatron and
HeartScan Imaging, Inc., refers to itself as Heart Scan Malaysia and is led by Beh Chor Khim, MD, Ph.D.,
Managing Director.
"Our group's plan is to develop a network of at least five heart disease risk assessment centers over the next
two and a half years," said Dr. Beh. "These centers will provide accurate, low-cost, non-invasive, cardiac
diagnostic services to the people of Malaysia. The first Imatron Ultrafast CT(R) scanner will be placed in
operation at a Heart Scan Malaysia center located in the capital city of Kuala Lumpur," Dr. Beh added.
Lewis Meyer, President and Chief Executive Officer of Imatron, commented, "Our focus in 1997 is on selling
equipment, and today's announcement represents a significant step in that direction. Malaysia is an important
market because of its strategic position in the Pacific Rim Region, and we look upon this sale as providing us
with tremendous credibility in what we believe to be a critical market for our Ultrafast CT(R) scanner.
"With the addition of this order, Imatron is now scheduled to ship five Ultrafast CT scanners in the first
quarter of 1997, which represents a 66 percent increase over the first quarter 1996," Mr. Meyer said.
Imatron Inc. is primarily engaged in designing, manufacturing and marketing high performance computed
tomography (CT) scanners based on the Company's proprietary scanning electron beam technology. Ultrafast
CT is a registered trademark of Imatron. Imatron's Ultrafast CT scanner is now in use at major medical centers
around the world, including The Mayo Clinic, University of Iowa, National Institutes of Health, UCLA,
University of Illinois, The Royal Brompton Hospital in London, Tokyo University Hospital, Beijing Hospital,
as well as many other major hospital centers. Imatron's Ultrafast CT is distributed in the United States,
Canada, Europe, and India by Siemens Medical Systems. Imatron's HeartScan Imaging Inc. subsidiary
provides Coronary Artery Disease Risk Assessment diagnostic services in a nationwide network of
Company-owned clinics.
Statements made in this news release that state the Company's or
management's intentions, hopes, beliefs, expectations or predictions for
the future are forward-looking statements that involve risk and
uncertainties. It is important to note that the Company's actual results
could differ materially from those projected in such forward-looking
statements. In addition to the factors set forth in the Company's 1995
Form 10-K, other important factors that could cause actual results to
differ materially include, but are not limited to, projected financial
results and industry-wide market factors.
SOURCE Imatron Inc.
-0- 03/24/97 /CONTACT: S. Lewis Meyer, President/CEO, Gary Brooks, VP Finance/CFO, or Lisa Kimberlin,
Investor Relations, 415-583-9964, all for Imatron; or Jody Martin of Sitrick And Company, 310-788-2850/
(IMAT)
CO: Imatron Inc. ST: California IN: MTC SU: PDT
[68751]
[ Back ]
Symbol:
|
